Relevance of Interferon‐Inducible Protein‐16 Rather than Anti–Interferon‐Inducible Protein‐16 Autoantibodies as a Clinical and Pathogenic Biomarker in Primary Sjögren's Syndrome: Comment on the Article by Baer et al. Issue 3 (25th February 2017)